Skip to content

Medical Management of Second Trimester Missed Miscarriage using a combination of Mifepristine-misoprostol versus Misoprostol alone

Medical Management of Second Trimester Missed Miscarriage using a combination of Mifepristine-misoprostol versus Misoprostol alone

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202311776445720
Enrollment
72
Registered
2023-11-06
Start date
2022-11-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Missed miscarriage

Interventions

Mifepristone
Calcium carbonate

Sponsors

Rabiatu Musa Ahmed
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients diagnosed with a missed miscarriage by pelvic ultrasound scan in the second trimester of pregnancy Patients who give informed consent to medical management of missed miscarriage in second trimester.

Exclusion criteria

Exclusion criteria: Patients with known allergy to mifepristone or misoprostol Patients with coagulation disorders Patients with a previous Caesarean delivery/myomectomy Life threatening bleeding, Contraindications to mifepristone or misoprostol, Patients who do not give consent Patients who opt for alternative means of miscarriage management Patients with multiple gestation

Design outcomes

Primary

MeasureTime frame
The primary outcome measures include; treatment success as defined by complete expulsion of the products of conception and no need for any additional medical and/or surgical intervention.

Secondary

MeasureTime frame
Secondary outcome measures include; intervention-complete expulsion interval, use of additional doses of misoprostol to effect expulsion, surgical intervention to complete miscarriage, use of oxytocin to aid expulsion of products of conception, side-effects of the medications used and complications of the miscarriage process such as excessive hemorrhage, retained placenta, etc.

Countries

Nigeria

Contacts

Public ContactRabiatu Musa Ahmed

Resident Doctor

rabiatuahmed33@gmail.com+2348160056766

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026